Impact of an Age-Adjusted Co-morbidity Index on Survival of Patients With Heart Failure Implanted With Cardiac Resynchronization Therapy Devices
- 1 October 2017
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 120 (7) , 1158-1165
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart FailureEuropean Journal of Heart Failure, 2016
- Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French RegistryJournal of the American Heart Association, 2016
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Predictors of mortality and morbidity in patients with chronic heart failureEuropean Heart Journal, 2005
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the ElderlyArchives of internal medicine (1960), 2002
- Cardiac Resynchronization in Chronic Heart FailureNew England Journal of Medicine, 2002
- Effect of Resynchronization Therapy Stimulation Site on the Systolic Function of Heart Failure PatientsCirculation, 2001
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987